APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,951 | -78.2% | 221,064 | -3.4% | 0.00% | – |
| Q2 2023 | $334,083 | -28.4% | 228,824 | -0.2% | 0.00% | – |
| Q1 2023 | $466,748 | -15.8% | 229,360 | -4.0% | 0.00% | – |
| Q4 2022 | $554,434 | -23.6% | 238,980 | +0.1% | 0.00% | – |
| Q3 2022 | $726,000 | -15.1% | 238,844 | 0.0% | 0.00% | – |
| Q2 2022 | $855,000 | -39.5% | 238,844 | -0.8% | 0.00% | – |
| Q1 2022 | $1,414,000 | -19.9% | 240,819 | +7.3% | 0.00% | – |
| Q4 2021 | $1,766,000 | -15.4% | 224,482 | +65.9% | 0.00% | – |
| Q3 2021 | $2,088,000 | -30.9% | 135,272 | +0.4% | 0.00% | – |
| Q2 2021 | $3,022,000 | -24.4% | 134,760 | +2.9% | 0.00% | – |
| Q1 2021 | $3,997,000 | -27.6% | 130,930 | -13.1% | 0.00% | – |
| Q4 2020 | $5,523,000 | +877.5% | 150,702 | +102.4% | 0.00% | – |
| Q3 2020 | $565,000 | +14.4% | 74,462 | +25.9% | 0.00% | – |
| Q2 2020 | $494,000 | +121.5% | 59,161 | -1.9% | 0.00% | – |
| Q1 2020 | $223,000 | – | 60,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $39,477,000 | 7.86% |
| RTW INVESTMENTS, LP | 281,402 | $6,312,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 187,995 | $4,217,000 | 0.09% |
| Anson Funds Management LP | 35,587 | $798,000 | 0.08% |
| Alyeska Investment Group, L.P. | 139,172 | $3,122,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 14,022 | $315,000 | 0.03% |
| JBF Capital, Inc. | 3,907 | $88,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,350 | $344,000 | 0.01% |
| Renaissance Technologies | 159,923 | $3,587,000 | 0.00% |
| QS Investors, LLC | 15,650 | $352,000 | 0.00% |